Trump Administration Drives Access to More High-Quality Medicare Plan Choices in 2020
Today, delivering on President Trump’s Advancing American Kidney Health Executive Order, the U.S.
CMS Expands Coverage of Ambulatory Blood Pressure Monitoring (ABPM)
The Centers for Medicare and Medicaid Services (CMS) announced today that Minnesota and Nebraska have become the 23rd and 24th states who have received approval under the Trump Administration for innovative demonstration projects that increase access to treatment for opioid use disorder (OUD) and other substance use disorders (SUD).
Today the Centers for Medicare and Medicaid Services (CMS) approved Louisiana’s Medicaid State Plan Amendment (SPA) authorizing the state to negotiate supplemental rebate agreements from prescription drug manufacturers.